RenaissanceRe (NYSE:RNR – Free Report) had its price objective upped by UBS Group from $229.00 to $238.00 in a research note published on Monday morning, Benzinga reports. They currently have a neutral rating on the insurance provider’s stock. Several other research firms also recently weighed in on RNR. Evercore ISI started coverage on shares of […]